What You Should Know:
– Kahun, a pioneer in medical knowledge structuring, has introduced a new AI Agent specifically designed for the pharmaceutical industry.
– The AI Agent aims to bridge the gap between medical knowledge and patient context, providing professionals with reliable and accessible drug-related information.
Addressing the Challenges of Pharma-Related Information
The rapid pace of drug development and research has made it increasingly difficult for healthcare professionals to stay up-to-date on the latest advancements. Kahun’s AI Agent addresses this challenge by structuring medical knowledge in a way that is easily accessible and understandable.
Benefits for Pharma Companies
By using Kahun’s AI Agent, pharma companies can:
- Improve Patient Management: Gain a deeper understanding of patient needs and identify potential treatment options.
- Decrease Drug Dropoff Rates: Provide professionals with the information they need to optimize patient outcomes.
- Promote Product Awareness: Increase awareness of existing and emerging pharmaceutical products.
“Launching a pharma-focused AI Agent is yet another important milestone for our team in helping improve the lives of patients by equipping healthcare professionals with tools that will make a positive difference in their workflows,” says Dr. Michal Tzuchman Katz, CEO and Co-Founder of Kahun. “New medical knowledge is becoming available at a rapid and exciting pace, but it adds a massive amount of information for healthcare professionals to navigate. With workloads already affecting physician-patient interactions, our tool is built to make knowledge easily accessible.”
